← All trials
NCT06522113
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 18, 2019
- Primary completion
- Oct 17, 2022
- Completion date
- Oct 17, 2022
- First posted
- Jul 26, 2024
- Last posted
- Aug 6, 2024
- Enrollment
- 378
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Incheon St.Mary's HospitalLead sponsor
- Incheon St.Mary's HospitalSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.